NO992785L - Fremgangsmåte til å heve konsentrasjonen av fri insulinlik vekstfaktor - Google Patents

Fremgangsmåte til å heve konsentrasjonen av fri insulinlik vekstfaktor

Info

Publication number
NO992785L
NO992785L NO992785A NO992785A NO992785L NO 992785 L NO992785 L NO 992785L NO 992785 A NO992785 A NO 992785A NO 992785 A NO992785 A NO 992785A NO 992785 L NO992785 L NO 992785L
Authority
NO
Norway
Prior art keywords
raising
concentration
growth factor
free insulin
insulin
Prior art date
Application number
NO992785A
Other languages
English (en)
Norwegian (no)
Other versions
NO992785D0 (no
Inventor
Katsuichi Sakano
Nobuyuki Higashihashi
Ryuji Hashimoto
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of NO992785D0 publication Critical patent/NO992785D0/no
Publication of NO992785L publication Critical patent/NO992785L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4743—Insulin-like growth factor binding protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO992785A 1996-12-27 1999-06-08 Fremgangsmåte til å heve konsentrasjonen av fri insulinlik vekstfaktor NO992785L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP34996896 1996-12-27
PCT/JP1997/004881 WO1998029451A1 (fr) 1996-12-27 1997-12-26 Procede pour elever la concentration de facteur de croissance libre apparente a l'insuline

Publications (2)

Publication Number Publication Date
NO992785D0 NO992785D0 (no) 1999-06-08
NO992785L true NO992785L (no) 1999-08-27

Family

ID=18407338

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992785A NO992785L (no) 1996-12-27 1999-06-08 Fremgangsmåte til å heve konsentrasjonen av fri insulinlik vekstfaktor

Country Status (6)

Country Link
US (2) US6428781B1 (fr)
EP (1) EP0965596A1 (fr)
AU (1) AU7891098A (fr)
CA (1) CA2276049A1 (fr)
NO (1) NO992785L (fr)
WO (1) WO1998029451A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6420518B1 (en) 1997-04-04 2002-07-16 Genetech, Inc. Insulin-like growth factor agonist molecules
US6121416A (en) 1997-04-04 2000-09-19 Genentech, Inc. Insulin-like growth factor agonist molecules
AU762351B2 (en) 1999-01-06 2003-06-26 Genentech Inc. Insulin-like growth factor (IGF) I mutant variants
JP2002535967A (ja) 1999-01-06 2002-10-29 ジェネンテック・インコーポレーテッド インシュリン様成長因子（ｉｇｆ）ｉ変異体
ATE389416T1 (de) 2000-05-16 2008-04-15 Genentech Inc Behandlung von knorpelerkrankungen
US6887851B2 (en) * 2001-09-18 2005-05-03 Bioexpertise, Llc IGF-binding protein-derived peptide
US6914049B2 (en) 2001-09-18 2005-07-05 Bioexpertise, Llc IGF-binding protein-derived peptide or small molecule
CA2504607A1 (fr) * 2002-11-14 2004-05-27 Wyeth Methodes et compositions permettant de traiter des troubles neurologiques
US20060276394A1 (en) * 2002-11-14 2006-12-07 Wyeth Methods and compositions for treating neurological disorders
WO2005016268A2 (fr) * 2003-08-08 2005-02-24 Mitochroma Research, Inc. Compositions alimentaires et procedes pour moduler un metabolisme
WO2012113900A1 (fr) 2011-02-24 2012-08-30 INSERM (Institut National de la Santé et de la Recherche Médicale) Dérivés de igfbp-3 et utilisations de ceux-ci
EP3632929A1 (fr) * 2018-10-02 2020-04-08 Ospedale San Raffaele S.r.l. Anticorps et leurs utilisations
WO2021094620A1 (fr) 2019-11-15 2021-05-20 Enthera S.R.L. Anticorps tmem219 et leurs utilisations thérapeutiques

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5163921A (ja) * 1974-11-27 1976-06-02 Sanyo Kokusaku Pulp Co Eragusanotanrisuruhoho
JPS5314605A (en) 1976-07-27 1978-02-09 Nippon Kokan Kk <Nkk> Controlling method for level protrusion in converter bottom
JPH0822869B2 (ja) 1986-06-25 1996-03-06 ヘキストジヤパン株式会社 サイトロジンｓ誘導体およびそれを含有する抗癌剤
JPS6479103A (en) * 1987-06-09 1989-03-24 Lion Corp External preparation
DE4120213C2 (de) 1991-06-19 2000-01-05 Boehringer Ingelheim Int Monoklonale Antikörper gegen das TNF-bindende Protein I (TNF-BP I)
JP3097199B2 (ja) 1991-08-23 2000-10-10 株式会社日立製作所 キャピラリー電気泳動装置
CA2224859A1 (fr) 1996-04-17 1997-10-23 Amitabh Gaur Inhibiteurs de ligands inhibant les proteines de liaison du facteur de croissance du type insuline et leurs procedes d'utilisation

Also Published As

Publication number Publication date
WO1998029451A1 (fr) 1998-07-09
NO992785D0 (no) 1999-06-08
CA2276049A1 (fr) 1998-07-09
US20030170240A1 (en) 2003-09-11
EP0965596A1 (fr) 1999-12-22
US6428781B1 (en) 2002-08-06
AU7891098A (en) 1998-07-31

Similar Documents

Publication Publication Date Title
NO992785L (no) Fremgangsmåte til å heve konsentrasjonen av fri insulinlik vekstfaktor
DE69324987D1 (de) Lösungsmittelfreie Organosiloxanzusammensetzung und ihre Verwendung
DE69730043D1 (de) Implantierbare eletrodenleitung
DE69732881D1 (de) Verwendung von zusammensetzungen mit stabilisierten enzymen
DE69703048D1 (de) Glaszusammensetzung, verfahren und verwendung
NO984031D0 (no) Bµreelement og fremgangsmÕte for fremstilling av samme
NO953298D0 (no) Belagt substrat og fremgangsmåte for dannelse derav
NO20003937L (no) FremgangsmÕte for tetting av forbindelsene i flersidige brønner
EP0912726A4 (fr) Procedes permettant d&#39;oxyder des liaisons bisulfure avec de l&#39;ozone
DE69501163D1 (de) Moduliertes Spektralellipsometer
DE69729570D1 (de) Fotpempfindliche zusammensetzung und deren verwendung
DE69106689D1 (de) Umkehrlackierungsverfahrenzusammensetzungen und ihre Verwendung.
FI980246A0 (fi) Menetelmä keittimen käyttämiseksi ja keitin
DE59710272D1 (de) Neue alpha-hydroxysäurederivate, ihre herstellung und verwendung
AU2367497A (en) Automatic downhole pump assembly and method for use of the same
NO972014D0 (no) Fremgangsmåte for å forhindre vekst av organismer på flater til konstruksjoner neddykket i en væske
ATE268760T1 (de) Neue carbonsäurederivate, ihre herstellung und verwendung
FI951980L (fi) Anti-inflammatorinen tekijä, menetelmä sen eristämiseksi sekä sen käyttö
FI972435A0 (fi) Aromia modifioiva koostumus
DE69718506D1 (de) Neue verwendung von kreatin
DE69016606D1 (de) Zusammensetzungen zur kontrollierten Haftverminderung und ihre Verwendung.
FI971245L (fi) Anti-inflammatorinen tekijä, menetelmä sen eristämiseksi sekä sen käyttö
DE59708683D1 (de) Kupfer-Chrom-Titan-Silizium-Legierung und ihre Verwendung
AU3178697A (en) Method and kit for the diagnosis of troponin i
NO982323D0 (no) FremgangsmÕte til regulering av algevekst

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application